Cormorant Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Cormorant Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-450,000	Closed	-$20.8M	–	79
2019 Q2	$20.8M	Sell	450,000 -50,000	-10%	-$1.4M	1.2%	29
2019 Q1	$12.2M	Sell	500,000 -80,756	-14%	-$1.68M	0.82%	37
2018 Q4	$8.28M	Sell	580,756 -19,244	-3%	-$292K	0.67%	38
2018 Q3	$9.12M	Sell	600,000 -68,743	-10%	-$1.05M	0.59%	37
2018 Q2	$11.2M	Hold	668,743	–	–	0.83%	37
2018 Q1	$10.9M	Sell	668,743 -31,257	-4%	-$501K	0.81%	26
2017 Q4	$8.96M	Sell	700,000 -200,000	-22%	-$2.27M	0.94%	28
2017 Q3	$11.1M	Hold	900,000	–	–	1.95%	18
2017 Q2	$7.53M	Hold	900,000	–	–	1.25%	25
2017 Q1	$8.05M	Sell	900,000 -250,000	-22%	-$2.66M	1.17%	31
2016 Q4	$10.1M	Hold	1,150,000	–	–	1.36%	23
2016 Q3	$7.76M	Buy	+1,150,000	New	+$4.45M	0.86%	40
2015 Q4	–	Sell	-850,000	Closed	-$3.88M	–	95
2015 Q3	$3.88M	Hold	850,000	–	–	0.62%	44
2015 Q2	$6.13M	Hold	850,000	–	–	0.81%	37
2015 Q1	$6.26M	Sell	850,000 -150,000	-15%	-$1.07M	0.97%	34
2014 Q4	$4.73M	Hold	1,000,000	–	–	0.73%	36
2014 Q3	$3.57M	Hold	1,000,000	–	–	0.73%	37
2014 Q2	$4.56M	Sell	1,000,000 -750,000	-43%	-$3.1M	1.21%	31
2014 Q1	$8.22M	Hold	1,750,000	–	–	1.89%	24
2013 Q4	$8.77M	Buy	+1,750,000	New	+$9.53M	2.54%	15

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Cormorant Asset Management's ARRY Position: Q3 2019 in Review

Cormorant Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 450,000 shares — an estimated $20.8M sold.

Cormorant Asset Management first reported a position in ARRY in Q4 2013 and held it in 20 quarters. The position peaked at $20.8M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Cormorant Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Cormorant Asset Management sold 450,000 Array Biopharma Inc shares in Q3 2019, an estimated $20.8M.
Cormorant Asset Management first reported a position in Array Biopharma Inc in Q4 2013 and held it in 20 quarters.
Cormorant Asset Management's Array Biopharma Inc position peaked at $20.8M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Cormorant Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.